Tungsten

Most people never think about tungsten. It sits in drinking water in a handful of regions, in industrial dusts around hard-metal manufacturing, and in some consumer and medical products. And yet in prospective human studies, higher urinary tungsten (a heavy metal element also called wolfram) has tracked with a faster path to chronic kidney disease, more new-onset diabetes, and more coronary artery calcium building up over the years.

This test measures how much tungsten your kidneys are currently clearing into your urine. It is best understood as a window into your recent exposure, not a diagnosis. A single value cannot label you as sick or safe, but a pattern of elevated levels can point to an environmental source worth finding and fixing.

Where Tungsten in Your Urine Comes From

Your body does not make tungsten. Every atom of it that shows up in your urine came from somewhere outside you: drinking water, food, air, occupational dust, or products that contain the metal. Most of what your body absorbs is excreted in urine within days, with a smaller fraction clearing more slowly over weeks to months. That is why urine is used as the biomarker: it turns over quickly enough to catch recent exposure.

In the general U.S. population, urinary tungsten sits at very low levels, and the vast majority of people have detectable but tiny amounts. In communities with known contamination in the local water supply, baseline urinary levels are substantially higher, and municipal water concentrations track with urinary values in the residents drinking from it. If your levels come back higher than expected, the most likely story is an environmental source, not an internal problem.

Kidney Disease Risk

The clearest human evidence for tungsten links it to the kidneys. In a prospective study of about 1,659 rural adults, a doubling of urinary tungsten was associated with roughly 27% to 31% higher odds of developing CKD (chronic kidney disease, defined as a sustained drop in the kidney's filtering ability) within 5 years. The signal held even after adjustment for diabetes and hypertension, the two biggest conventional drivers of kidney disease.

For a rarer subtype called CKDu (chronic kidney disease of unknown origin, meaning kidney failure that shows up without the usual causes), people with the highest urinary tungsten exposure (above the 95th percentile) had substantially higher odds of that diagnosis compared with lower-exposed peers. Researchers hypothesize the damage is happening in the deeper tubular parts of the kidney rather than the filtering units, because protein leakage into urine was not linked to tungsten in the same way, a pattern consistent with animal data showing tubular epithelial cell injury.

Diabetes and Insulin Resistance

The same rural cohort study followed 1,609 adults over time and found that higher urinary tungsten was associated with about 28% higher risk of developing new diabetes, along with modestly higher fasting glucose and higher HOMA-IR (a calculation that estimates how resistant your cells have become to insulin). The association held after adjustment for arsenic, cadmium, and lead, three other metals known to affect metabolism.

A separate cross-sectional analysis in U.S. adults found that people in the top quarter of urinary tungsten had more than double the odds of diabetes compared with those in the bottom quarter. If you already have insulin resistance or a family history of type 2 diabetes, an elevated tungsten result is one more piece of the puzzle worth taking seriously, because the association survives adjustment for the usual metabolic suspects.

Cardiovascular Signals

Vascular evidence is real but less consistent than the kidney and diabetes findings. In MESA (Multi-Ethnic Study of Atherosclerosis, a large U.S. cardiovascular cohort of 6,418 adults), the highest versus lowest quartile of urinary tungsten was associated with 45% higher coronary artery calcium (a direct measure of plaque hardening in the arteries around the heart) tracked over 10 years. A later MESA analysis of 6,599 participants also found that higher urinary tungsten was prospectively associated with about 20% higher risk of new cardiovascular events and 16% higher all-cause mortality.

In an earlier NHANES analysis, urinary tungsten levels were about 49% higher in people with peripheral artery disease (narrowing of the leg arteries) than in those without it. Higher urinary tungsten has also been linked to higher odds of stroke overall, with a stronger signal in younger adults (roughly a doubling of the odds in adults aged 18 to 50).

One prospective study of about 2,726 adults in the Strong Heart cohort did not find an overall link between baseline urinary tungsten and new cardiovascular events. Reconciling this with the calcium, MESA, and stroke findings is important: tungsten's vascular effect appears to be modified by urinary molybdenum, a related trace element that tungsten can compete with in the body. In the highest molybdenum group, higher tungsten was associated with lower cardiovascular disease risk; in the lowest molybdenum group, the direction reversed. Rather than being contradictory, these results suggest that tungsten's risk is not a stand-alone number, it is a phenotype that depends on the trace-element context around it.

Other Reported Associations

Higher urinary tungsten has been linked to about twice the odds of frailty in older adults, higher risk of fatty liver phenotypes (fat buildup in the liver not driven by alcohol), lower serum α-Klotho (a protein that tends to fall with biological aging), and higher odds of chronic pain overlapping with depression. These findings come from cross-sectional NHANES analyses, so they cannot prove tungsten is causing these conditions. What they show is that the same metal shows up across multiple aging-related outcomes.

When Results Can Be Misleading

Urinary tungsten is one of the least stable metal measurements in a single spot sample. In a controlled study of 11 healthy adult men sampled repeatedly over 3 months, the creatinine-adjusted intraclass correlation coefficient (a statistic that runs from 0 to 1, where higher values mean the measurement reflects a stable personal setpoint) for tungsten came in very low (roughly 0.01 to 0.14), essentially showing no reproducibility from one spot sample to the next. Longer-term data from MESA, where samples were collected years apart, suggest somewhat better stability in some populations, but short-term spot-to-spot variability remains the dominant practical problem.

The practical consequences:

• Timing of collection matters: because most absorbed tungsten leaves your body within days, a sample taken during a week of low exposure can look reassuring even if your usual environment is not.
• Urine dilution distorts values: how much water you drank before the collection dramatically changes the raw number, which is why results are typically reported with creatinine correction. Creatinine correction itself is imperfect because creatinine production varies by sex, age, and muscle mass.
• A single sample misses high exposure: a spot sample identified only a minority of people (sensitivity of about 0.27 to 0.60) who were actually in the top third of their 3-month average exposure, even though it correctly cleared most of the less-exposed group (specificity of about 0.73 to 0.85).
• Reference values vary regionally: what counts as elevated depends on the local baseline, which shifts with water source, geology, and occupation.

Why One Reading Is Not Enough

For most biomarkers, tracking a trend is more useful than staring at a single number. For urinary tungsten, this is not a preference, it is a requirement. Because within-person variability is so high, a single spot value tells you about the past few days and almost nothing reliable about your usual exposure.

The strongest evidence-based approach is repeat testing. Studies that used 2 to 3 spot samples classified people's true exposure category far better than any single sample. A reasonable pattern for someone who wants a real answer: get a baseline, then get 1 or 2 additional samples over the following weeks to months, ideally on different days and with normal hydration. If the pattern is consistently high, you have signal. If only one sample was high and the others normal, you probably caught a spike from a single exposure event.

If you make a change (switching drinking water source, changing workplace controls, using different products), retesting after roughly 2 to 4 weeks should capture whether the change is affecting your levels, since the fast urinary excretion phase clears within days.

What to Do With an Elevated Result

Because this is an exposure biomarker without established clinical cutpoints, the response to a high value is investigative, not pharmacologic. The most useful next steps combine finding the source and evaluating the organs most likely to be affected:

• Confirm the finding: retest with 1 to 2 additional urine samples on different days before assuming your baseline is truly high. Given the poor reproducibility of a single sample, confirmation is essential.
• Trace the exposure: consider testing your drinking water (private wells and certain municipal supplies in mineralized regions can carry tungsten) and reviewing occupational exposures. Hard-metal manufacturing, tool sharpening, and some military and medical settings are documented sources.
• Check the kidneys: because the strongest human outcome data is for kidney disease, pair the result with a creatinine, cystatin C, and eGFR to see whether kidney filtration is trending down over time. A urine albumin-to-creatinine ratio can rule out concurrent glomerular disease.
• Check metabolic health: given the diabetes signal, a fasting glucose, HbA1c, and fasting insulin (used to calculate HOMA-IR) provide a metabolic snapshot that adds context.
• Consider referral: for persistently elevated levels or documented occupational exposure, an occupational or environmental medicine specialist can help investigate the source and interpret the pattern in context.

What the evidence does not support is treating an elevated urinary tungsten value as a diagnosis on its own. It is a signal that deserves an investigation, and the pattern across repeat samples matters more than any single number.